|
1
|
Strand V, Kosinski M, Gnanasakthy A,
Mallya U and Mpofu S: Secukinumab treatment in rheumatoid arthritis
is associated with incremental benefit in the clinical outcomes and
HRQoL improvements that exceed minimally important thresholds.
Health Qual Life Outcomes. 12:312014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bao J, Yue T, Liu W, Zhang Q, Zhou L, Xu
HJ and Dai SM: Secondary failure to treatment with recombinant
human IL-1 receptor antagonist in Chinese patients with rheumatoid
arthritis. Clin Rheumatol. 30:697–701. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang S, Lukey P, Beerahee M and Hoke F:
Population pharmacokinetics of losmapimod in healthy subjects and
patients with rheumatoid arthritis and chronic obstructive
pulmonary diseases. Clin Pharmacokinet. 52:187–198. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen L, Qi H, Jiang D, Wang R, Chen A, Yan
Z and Xiao J: The new use of an ancient remedy: A double-blinded
randomized study on the treatment of rheumatoid arthritis. Am J
Chin Med. 41:263–280. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen XX, Dai Q, Huang AB, Wu HX, Zhao DB,
Li XF, Hu SX, Yang NP, Tao Y, Xu JH, et al: A multicenter,
randomized, double-blind clinical trial of combination therapy with
Anbainuo, a novel recombinant human TNFRII: Fc fusion protein, plus
methotrexate versus methotrexate alone or Anbainuo alone in Chinese
patients with moderate to severe rheumatoid arthritis. Clin
Rheumatol. 32:99–108. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yadlapati S and Efthimiou P:
Autoimmune/inflammatory arthritis associated lymphomas: Who is at
risk? Biomed Res Int. 863–1061. 2016.
|
|
7
|
Eneljung T, Tengvall S, Jirholt P,
Henningsson L, Holmdahl R, Gustafsson K and Gjertsson I:
Antigen-specific gene therapy after immunisation reduces the
severity of collagen-induced arthritis. Clin Dev Immunol.
3450922013.PubMed/NCBI
|
|
8
|
Li J, Li J, Chen R and Cai G: Targeting
NF-kB and TNF-α activation by electroacupuncture to suppress
collagen-induced rheumatoid arthritis in model rats. Altern Ther
Health Med. 21:26–34. 2015.PubMed/NCBI
|
|
9
|
Liu F, Cheng W, Pappoe F, Hu X, Wen H, Luo
Q, Wang S, Deng F, Xie Y, Xu Y and Shen J: Schistosoma japonicum
cystatin attenuates murine collagen-induced arthritis. Parasitol
Res. 2016. View Article : Google Scholar
|
|
10
|
Li N, Wang JC, Liang TH, Zhu MH, Wang JY,
Fu XL, Zhou JR, Zheng SG, Chan P and Han J: Pathologic finding of
increased expression of interleukin-17 in the synovial tissue of
rheumatoid arthritis patients. Int J Clin Exp Pathol. 6:1375–1379.
2013.PubMed/NCBI
|
|
11
|
Fleischmann R, Kremer J, Tanaka Y, Gruben
D, Kanik K, Koncz T, Krishnaswami S, Wallenstein G, Wilkinson B,
Zwillich SH and Keystone E: Efficacy and safety of tofacitinib in
patients with active rheumatoid arthritis: Review of key Phase 2
studies. Int J Rheum Dis. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Farzaei MH, Farzaei F, Abdollahi M,
Abbasabadi Z, Abdolghaffari AH and Mehraban B: A mechanistic review
on medicinal plants used for rheumatoid arthritis in traditional
Persian medicine. J Pharm Pharmacol. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kochi Y: Genetic background of tolerance
breakdown in rheumatoid arthritis. Nihon Rinsho Meneki Gakkai
Kaishi. 33:48–56. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tang W and Zuo JP: Immunosuppressant
discovery from Tripterygium wilfordii Hook f: The novel triptolide
analog (5R)-5-hydroxytriptolide (LLDT-8). Acta Pharmacol Sin.
33:1112–1118. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhou R, Zheng SX, Tang W, He PL, Li XY,
Yang YF, Li YC, Geng JG and Zuo JP: Inhibition of inducible
nitric-oxide synthase expression by (5R)-5-hydroxytriptolide in
interferon-gamma- and bacterial lipopolysaccharide-stimulated
macrophages. J Pharmacol Exp Ther. 316:121–128. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ren YX, Zhou R, Tang W, Wang WH, Li YC,
Yang YF and Zuo JP: (5R)-5-hydroxytriptolide (LLDT-8) protects
against bleomycin-induced lung fibrosis in mice. Acta Pharmacol
Sin. 28:518–525. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rosenthal KS, Mikecz K, Steiner HL, Glant
TT, Finnegan A, Carambula RE and Zimmerman DH: Rheumatoid arthritis
vaccine therapies: Perspectives and lessons from therapeutic ligand
epitope antigen presentation system vaccines for models of
rheumatoid arthritis. Expert Rev Vaccines. 14:891–908. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen Y, Xian PF, Yang L and Wang SX:
MicroRNA-21 promotes proliferation of fibroblast-like synoviocytes
through mediation of NF-kappaB nuclear translocation in a rat model
of collagen-induced rheumatoid arthritis. Biomed Res Int.
92790782016.PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kanbe K, Oh K, Chiba J, Inoue Y, Taguchi M
and Yabuki A: Analysis of mitogen-activated protein kinases in bone
and cartilage of patients with rheumatoid arthritis treated with
abatacept. Clin Med Insights Arthritis Musculoskelet Disord.
9:51–56. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang H, Chen W, Wang L, Li F, Zhang C and
Xu L: Tumor necrosis factor receptor-associated factor 6 promotes
migration of rheumatoid arthritis fibroblast-like synoviocytes. Mol
Med Rep. 11:2761–2766. 2015.PubMed/NCBI
|
|
22
|
Cordova KN, Willis VC, Haskins K and
Holers VM: A citrullinated fibrinogen-specific T cell line enhances
autoimmune arthritis in a mouse model of rheumatoid arthritis. J
Immunol. 190:1457–1465. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Park KS, Park MJ, Cho ML, Kwok SK, Ju JH,
Ko HJ, Park SH and Kim HY: Type II collagen oral tolerance;
mechanism and role in collagen-induced arthritis and rheumatoid
arthritis. Mod Rheumatol. 19:581–589. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kakimoto K, Kojima Y, Ishii K, Onoue K and
Maeda H: The suppressive effect of gelatin-conjugated superoxide
dismutase on disease development and severity of collagen-induced
arthritis in mice. Clin Exp Immunol. 94:241–246. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu J, Wang Y, Huang C, Xu J, Li Z, Xu L,
He L, Sun Y, Wang Y, Xu S, Zhao P, et al: Efficacy and safety of
Xinfeng capsule in patients with rheumatoid arthritis: A
multi-center parallel-group double-blind randomized controlled
trial. J Tradit Chin Med. 35:487–498. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Choi JH, Lee JH, Roh KH, Seo SK, Choi IW,
Park SG, Lim JG, Lee WJ, Kim MH, Cho KR and Kim YJ: Gallium nitrate
ameliorates type II collagen-induced arthritis in mice. Int
Immunopharmacol. 20:269–275. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Varadé J, Lamas JR, Fernández-Arquero M,
Jover JA, de la Concha EG, Martínez A, Fernández-Gutierrez B and
Urcelay E: NO role of NOS2A susceptibility polymorphisms in
rheumatoid arthritis. Nitric Oxide. 21:171–174. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kimura T, Mogi C, Tomura H, Kuwabara A, Im
DS, Sato K, Kurose H, Murakami M and Okajima F: Induction of
scavenger receptor class B type I is critical for simvastatin
enhancement of high-density lipoprotein-induced anti-inflammatory
actions in endothelial cells. J Immunol. 181:7332–7340. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Abramson SB, Amin AR, Clancy RM and Attur
M: The role of nitric oxide in tissue destruction. Best Pract Res
Clin Rheumatol. 15:831–845. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liang Q, Ju Y, Chen Y, Wang W, Li J, Zhang
L, Xu H, Wood RW, Schwarz EM, Boyce BF, Wang Y and Xing L:
Lymphatic endothelial cells efferent to inflamed joints produce
iNOS and inhibit lymphatic vessel contraction and drainage in
TNF-induced arthritis in mice. Arthritis Res Ther. 18:622016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Salerno L, Sorrenti V, Di Giacomo C, Romeo
G and Siracusa MA: Progress in the development of selective nitric
oxide synthase (NOS) inhibitors. Curr Pharm Des. 8:177–200. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Markovics A, Ocskó T, Katz RS, Buzás EI,
Glant TT and Mikecz K: Immune recognition of citrullinated
proteoglycan aggrecan epitopes in mice with proteoglycan-induced
arthritis and in patients with rheumatoid arthritis. PLoS One.
11:e01602842016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sarban S, Isikan UE, Kocabey Y and
Kocyigit A: Relationship between synovial fluid and plasma
manganese, arginase, and nitric oxide in patients with rheumatoid
arthritis. Biol Trace Elem Res. 115:97–106. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lee YA, Choi HM, Lee SH, Hong SJ, Yang HI,
Yoo MC and Kim KS: Hypoxia differentially affects IL-1β-stimulated
MMP-1 and MMP-13 expression of fibroblast-like synoviocytes in an
HIF-1α-dependent manner. Rheumatology (Oxford). 51:443–450. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lee YA, Ji HI, Lee SH, Hong SJ, Yang HI,
Yoo M Chul and Kim KS: The role of adiponectin in the production of
IL-6, IL-8, VEGF and MMPs in human endothelial cells and
osteoblasts: Implications for arthritic joints. Exp Mol Med.
46:e722014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Shen Y, Jiang T, Wang R, He S, Guo M, Zuo
J and He D: (5R)-5-Hydroxytriptolide (LLDT-8) inhibits
osteoclastogenesis via RANKL/RANK/OPG signaling pathway. BMC
Complement Altern Med. 15:772015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Remuzgo-Martínez S, Genre F, López-Mejías
R, Ubilla B, Mijares V, Pina T, Corrales A, Blanco R, Martín J,
Llorca J and González-Gay MA: Expression of osteoprotegerin and its
ligands, RANKL and TRAIL, in rheumatoid arthritis. Sci Rep.
6:297132016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ho TY, Santora K, Chen JC, Frankshun AL
and Bagnell CA: Effects of relaxin and estrogens on bone remodeling
markers, receptor activator of NF-kB ligand (RANKL) and
osteoprotegerin (OPG), in rat adjuvant-induced arthritis. Bone.
48:1346–1353. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Feng X, Lv C, Wang F, Gan K, Zhang M and
Tan W: Modulatory effect of 1,25-dihydroxyvitamin D 3 on IL1
β-induced RANKL, OPG, TNF α, and IL-6 expression in human
rheumatoid synoviocyte MH7A. Clin Dev Immunol. 2013:1601232013.
View Article : Google Scholar : PubMed/NCBI
|
